CN103874502B - 用于控制病原体的氨基酸序列 - Google Patents

用于控制病原体的氨基酸序列 Download PDF

Info

Publication number
CN103874502B
CN103874502B CN201280050943.4A CN201280050943A CN103874502B CN 103874502 B CN103874502 B CN 103874502B CN 201280050943 A CN201280050943 A CN 201280050943A CN 103874502 B CN103874502 B CN 103874502B
Authority
CN
China
Prior art keywords
peptide
seqidno
group
peptides
oreochromicin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280050943.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN103874502A (zh
Inventor
J·阿科斯塔阿尔巴
M·P·埃斯特拉达加西亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of CN103874502A publication Critical patent/CN103874502A/zh
Application granted granted Critical
Publication of CN103874502B publication Critical patent/CN103874502B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201280050943.4A 2011-09-30 2012-10-01 用于控制病原体的氨基酸序列 Active CN103874502B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2011-0181 2011-09-30
CU20110181A CU24076B1 (es) 2011-09-30 2011-09-30 Composición para el control de patógenos
PCT/CU2012/000005 WO2013044890A1 (es) 2011-09-30 2012-10-01 Secuencias de aminoácidos para el control de patógenos

Publications (2)

Publication Number Publication Date
CN103874502A CN103874502A (zh) 2014-06-18
CN103874502B true CN103874502B (zh) 2015-11-25

Family

ID=47143463

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280050943.4A Active CN103874502B (zh) 2011-09-30 2012-10-01 用于控制病原体的氨基酸序列

Country Status (16)

Country Link
US (1) US9549978B2 (enExample)
EP (1) EP2767290B1 (enExample)
JP (1) JP6034385B2 (enExample)
KR (1) KR101986358B1 (enExample)
CN (1) CN103874502B (enExample)
AR (1) AR088176A1 (enExample)
AU (1) AU2012315083B2 (enExample)
BR (1) BR112014007491B1 (enExample)
CA (1) CA2849040C (enExample)
CL (1) CL2014000760A1 (enExample)
CU (1) CU24076B1 (enExample)
ES (1) ES2600903T3 (enExample)
MX (1) MX348934B (enExample)
RU (1) RU2636001C2 (enExample)
WO (1) WO2013044890A1 (enExample)
ZA (1) ZA201402171B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262485B (zh) * 2014-04-15 2017-01-18 四川农业大学 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法
CN105061575B (zh) * 2015-02-03 2020-08-04 浙江海洋学院 一种金枪鱼肝脏抗菌肽及其制备方法和用途
CN109350731A (zh) * 2018-12-18 2019-02-19 汕尾市维明生物科技股份有限公司 一种罗非鱼蛋白肽在制备免疫制剂中的应用
CN112979763A (zh) * 2021-03-03 2021-06-18 山东大学 一种基于可溶性疏水载体抗菌肽Oreoch-2的液相合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200825098A (en) * 2006-12-05 2008-06-16 Academia Sinica Anti-microbal peptides and uses thereof
CN101559214A (zh) * 2009-05-27 2009-10-21 珍奥集团股份有限公司 具有增强免疫功能作用的组合物及其用途
CN102021172A (zh) * 2010-06-23 2011-04-20 广西壮族自治区水产研究所 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030056244A1 (en) * 2000-05-02 2003-03-20 Ning Huang Feed additive compositions and methods
US6753407B2 (en) * 2000-08-15 2004-06-22 North Carolina State University Antimicrobial peptides isolated from fish
AU2001287178A1 (en) * 2000-08-15 2002-02-25 North Carolina State University Antimicrobial peptides isolated from mast cells
WO2004018706A2 (en) * 2002-08-22 2004-03-04 National Research Council Of Canada A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
EP1838331A4 (en) * 2004-12-15 2012-12-26 Univ Colorado ANTIMICROBIAL PEPTIDES AND METHOD OF USE
RU2302467C1 (ru) * 2005-12-01 2007-07-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Пептиды латарцины, проявляющие антимикробную активность
US20090186047A1 (en) * 2006-04-25 2009-07-23 Intercell Ag HCV Vaccinations
WO2009149554A1 (en) * 2008-06-11 2009-12-17 National Research Council Of Canada Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa)
CN103665170A (zh) * 2008-12-05 2014-03-26 安吉奥开米公司 肽治疗剂轭合物及其应用
US20100184684A1 (en) * 2009-01-06 2010-07-22 C3 Jian, Inc. Antibacterial and antifungal peptides
US8389679B2 (en) * 2009-02-05 2013-03-05 The Regents Of The University Of California Targeted antimicrobial moieties
EP2661451B1 (en) * 2011-01-07 2019-10-09 Valiant Biopharma SDN BHD Antimicrobial fusion compounds and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200825098A (en) * 2006-12-05 2008-06-16 Academia Sinica Anti-microbal peptides and uses thereof
CN101559214A (zh) * 2009-05-27 2009-10-21 珍奥集团股份有限公司 具有增强免疫功能作用的组合物及其用途
CN102021172A (zh) * 2010-06-23 2011-04-20 广西壮族自治区水产研究所 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
大口黑鲈抗菌肽hepcidin+cDNA序列和结构分析;白俊杰等;《广州海洋大学学报》;20080229;第28卷(第1期);第1-5页 *
尼罗罗非鱼Hepcidin基因结构与序列分析;黄文树等;《厦门大学学报》;20070531;第46卷(第3期);第390-395页 *

Also Published As

Publication number Publication date
ZA201402171B (en) 2015-12-23
CU24076B1 (es) 2015-01-29
KR101986358B1 (ko) 2019-06-05
CA2849040C (en) 2019-11-26
ES2600903T3 (es) 2017-02-13
KR20140070597A (ko) 2014-06-10
AR088176A1 (es) 2014-05-14
RU2014117659A (ru) 2015-11-10
CA2849040A1 (en) 2013-04-04
CL2014000760A1 (es) 2014-08-22
CU20110181A7 (es) 2013-05-31
US9549978B2 (en) 2017-01-24
US20140294871A1 (en) 2014-10-02
MX348934B (es) 2017-07-03
EP2767290A1 (en) 2014-08-20
WO2013044890A1 (es) 2013-04-04
AU2012315083A1 (en) 2014-05-08
AU2012315083B2 (en) 2016-02-25
BR112014007491A2 (pt) 2017-04-04
CN103874502A (zh) 2014-06-18
EP2767290B1 (en) 2016-09-14
BR112014007491B1 (pt) 2022-03-03
JP6034385B2 (ja) 2016-11-30
RU2636001C2 (ru) 2017-11-17
MX2014003892A (es) 2014-07-09
JP2014533931A (ja) 2014-12-18

Similar Documents

Publication Publication Date Title
Klüver et al. Synthesis and structure–activity relationship of β‐defensins, multi‐functional peptides of the immune system
Noga et al. Piscidin 4, a novel member of the piscidin family of antimicrobial peptides
Wang et al. Functions of antimicrobial peptides in gut homeostasis
US11603391B2 (en) CATH2 derivatives
KR102228324B1 (ko) 에이메리아에 대한 면역 반응을 증진시키거나, 에이메리아 감염을 제한하는 조성물 및 방법
CN103874502B (zh) 用于控制病原体的氨基酸序列
US20190233483A1 (en) Antimicrobial Peptides Based on CMAP27
EP1724342B1 (en) Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli
KR100854594B1 (ko) 톨-유사 수용체-5 자극 활성이 강화된 ｐａｓ-플라젤린융합 단백질
CN116284281B (zh) G型产气荚膜梭菌的重组蛋白、疫苗及应用
KR20120062504A (ko) 세포표면에서 발현되는 항균 펩타이드 다중합체
US20240010690A1 (en) Oral vaccine, method of preparation and use thereof
JP2018016548A (ja) 抗微生物ポリペプチド
Kindrachuk Host and pathogen sensory systems as targets for therapeutic intervention

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant